Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.
Tympanogen has raised $1.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Tympanogen's investors include MassChallenge, Virginia Venture Partners, ShockVentures, NO/LA Angel Network, Virginia Catalyst.
Tympanogen is headquartered in Richmond, United States.
Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.
Tympanogen is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tympanogen — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/tympanogen. Accessed July 19, 2026.
VCBacked. (2025). Tympanogen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tympanogen
{{cite web |title=Tympanogen — Funding & Investors |url=https://www.vcbacked.co/company/tympanogen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated